Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

"Von Willebrand disease type 2M: Correlation between genotype and phenotype": Comment from Favaloro.

Journal of thrombosis and haemostasis : JTH·2022

Same author

Getting smart with coagulation.

Journal of thrombosis and haemostasis : JTH·2022

Same author

A multi-laboratory assessment of lupus anticoagulant assays performed on the ACL TOP 50 family for harmonized testing in a large laboratory network.

International journal of laboratory hematology·2022

Same author

Antibodies against Platelet Factor 4 and Their Associated Pathologies: From HIT/HITT to Spontaneous HIT-Like Syndrome, to COVID-19, to VITT/TTS.

Antibodies (Basel, Switzerland)·2022

Same author

Editorial Compilation XI.

Seminars in thrombosis and hemostasis·2022

Same author

The Benefits of Heparin Use in COVID-19: Pleiotropic Antiviral Activity beyond Anticoagulant and Anti-Inflammatory Properties.

Seminars in thrombosis and hemostasis·2022

Same journal

A follow-up cohort study on secondary findings in cancer predisposition genes from 20,205 Chinese individuals.

Clinica chimica acta; international journal of clinical chemistry·2026

Same journal

Chemometric profiling reveals selective circulating bile acid remodeling in Alzheimer's disease.

Clinica chimica acta; international journal of clinical chemistry·2026

Same journal

Serum sialic acid is independently associated with cerebrovascular atherosclerotic stenosis severity and total vascular burden: A retrospective cohort study.

Clinica chimica acta; international journal of clinical chemistry·2026

Same journal

Measurement of low-density lipoprotein cholesterol and other circulating lipids in Brazil: a systematic literature review.

Clinica chimica acta; international journal of clinical chemistry·2026

Same journal

Reference intervals for venous blood gas measurement in a healthy Chinese population.

Clinica chimica acta; international journal of clinical chemistry·2026

Same journal

Multiplex methylation marker analysis for ctDNA detection in liquid biopsies from anal cancer patients: an HPV-independent approach.

Clinica chimica acta; international journal of clinical chemistry·2026

See all related articles

Search research articles

Related Experiment Video

Updated: Jun 19, 2026

The Nijmegen Hemostasis Assay: Simultaneous Fluorogenic Measurement of Thrombin and Plasmin Generation in a Single Well

The Nijmegen Hemostasis Assay: Simultaneous Fluorogenic Measurement of Thrombin and Plasmin Generation in a Single Well

Published on: February 27, 2026

Glanzmann thrombasthenia: an update.

Massimo Franchini¹, Emmanuel J Favaloro, Giuseppe Lippi

¹Servizio di Immunoematologia e Medicina Trasfusionale, Dipartimento di Patologia e Medicina di Laboratorio, Azienda Ospedaliero-Universitaria di Parma, Parma, Italy. mfranchini@ao.pr.it

Clinica Chimica Acta; International Journal of Clinical Chemistry

|October 27, 2009

Summary

This summary is machine-generated.

Glanzmann thrombasthenia (GT) is a rare bleeding disorder affecting platelet glycoprotein IIb/IIIa. This review covers GT molecular defects, diagnosis, and treatment for managing mucocutaneous bleeding.

More Related Videos

Fingerprinting Cardiolipin in Leukocytes by Mass Spectrometry for a Rapid Diagnosis of Barth Syndrome

Fingerprinting Cardiolipin in Leukocytes by Mass Spectrometry for a Rapid Diagnosis of Barth Syndrome

Published on: March 23, 2022

Thrombus Profiling Assay: A Microfluidics-Based Platform for Comprehensively Characterizing Biomechanical Thrombogenesis

Thrombus Profiling Assay: A Microfluidics-Based Platform for Comprehensively Characterizing Biomechanical Thrombogenesis

Published on: January 9, 2026

Related Experiment Videos

Last Updated: Jun 19, 2026

The Nijmegen Hemostasis Assay: Simultaneous Fluorogenic Measurement of Thrombin and Plasmin Generation in a Single Well

The Nijmegen Hemostasis Assay: Simultaneous Fluorogenic Measurement of Thrombin and Plasmin Generation in a Single Well

Published on: February 27, 2026

Fingerprinting Cardiolipin in Leukocytes by Mass Spectrometry for a Rapid Diagnosis of Barth Syndrome

Fingerprinting Cardiolipin in Leukocytes by Mass Spectrometry for a Rapid Diagnosis of Barth Syndrome

Published on: March 23, 2022

Thrombus Profiling Assay: A Microfluidics-Based Platform for Comprehensively Characterizing Biomechanical Thrombogenesis

Thrombus Profiling Assay: A Microfluidics-Based Platform for Comprehensively Characterizing Biomechanical Thrombogenesis

Published on: January 9, 2026

Area of Science:

Hematology
Genetics
Molecular Biology

Background:

Glanzmann thrombasthenia (GT) is a rare autosomal recessive bleeding disorder.
It involves defects in platelet glycoprotein (GP) IIb/IIIa, crucial for platelet aggregation.
Impaired aggregation leads to variable mucocutaneous bleeding.

Purpose of the Study:

To review the main characteristics of Glanzmann thrombasthenia.
To focus on molecular defects underlying the condition.
To discuss diagnostic evaluation and current treatment strategies.

Main Methods:

Literature review of Glanzmann thrombasthenia.
Analysis of molecular defects in platelet GP IIb/IIIa.
Synthesis of diagnostic and therapeutic approaches.

Main Results:

GT is characterized by qualitative/quantitative abnormalities of GP IIb/IIIa.
Defective GP IIb/IIIa impairs platelet aggregation and thrombus formation.
Clinical manifestations range from mild bruising to severe hemorrhage.

Conclusions:

Understanding molecular defects is key to diagnosing GT.
Effective management involves tailored diagnostic and treatment strategies.
Further research can improve outcomes for GT patients.